Association of systemic steroids and mycophenolate mofetil as rescue therapy for uveitic choroidal neovascularization unresponsive to the traditional immunesuppressants: Interventional case series

International Ophthalmology

Volumn 30, Issue 5, 2010, Pages 583-590

  Neri, Piergiorgio ^a   Manoni, Mara ^a,b   Fortuna, Cinzia ^a,b   Lettieri, Marta ^a,b   Mariotti, Cesare ^a,b   Giovannini, Alfonso ^a,b  

^a UNIVERSITY HOSPITAL OF TRIESTE   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Choroidal neovascularization; Mycophenolate mofetil; Systemic steroids; Uveitis

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERVENTION STUDY; MAINTENANCE THERAPY; MALE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; STEROID THERAPY; SUBRETINAL NEOVASCULARIZATION; UVEITIS; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADMINISTRATION, ORAL; ADULT; CHOROIDAL NEOVASCULARIZATION; DRUG THERAPY, COMBINATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; MYCOPHENOLIC ACID; PREDNISOLONE; SALVAGE THERAPY; UVEITIS; VISUAL ACUITY;

EID: 78649315635     PISSN: 01655701     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10792-009-9323-x     Document Type: Article

References (35)

1. PR Parvan CE Margo 1996 Submacular neovascular membrane and focal granulomatous inflammation Ophthalmology 103 586 589
2. JV Forrester J Liversidge HS Dua, et al. 1990 Comparison of clinical experimental uveitis Curr Eye Res 9 75 84 10.3109/02713689008999424 2143464
3. AA Okada T Wakabayashi E Kojima, et al. 2004 Trans-tenon's retrobulbar triamcinolone infusion for small choroidal neovascularization Br J Ophthalmol 88 1097 1098 1:STN:280:DC%2BD2czlsVygtg%3D%3D 10.1136/bjo.2003.039719 15258036 (Pubitemid 39013161)
4. CJ Flaxel SL Owens B Mulholland, et al. 1998 The use of corticosteroids for choroidal neovascularization in young patients Eye 12 Pt 2 266 272 9683952
5. JI Lim CJ Flaxel L LaBree 2006 Photodynamic therapy for choroidal neovascularisation secondary to inflammatory chorioretinal disease Ann Acad Med Singap 35 3 198 202 16625270
6. C Gerth G Spital A Lommatzsch A Heiligenhaus D Pauleikhoff 2006 Photodynamic therapy for choroidal neovascularization in patients with multifocal choroiditis and panuveitis Eur J Ophthalmol 16 1 111 118 1:STN:280:DC%2BD287gvVGntA%3D%3D 16496254
7. ES Lit RY Kim DJ Damico 2001 Surgical removal of subfoveal choroidal neovascularization without removal of posterior hyaloid: a consecutive series in younger patients Retina 21 4 317 323 1:STN:280:DC%2BD3Mvmtl2jsA%3D%3D 10.1097/00006982-200108000-00004 11508876
8. Vitale AT, Foster CS (2002) Corticosteroids. In: Foster CS, Vitale AT (eds) Diagnosis and treatment of uveitis. Philadelphia, W.B. Saunders Company, pp 142-158
9. P Ferrante A Ramsey C Bunce S Lightman 2004 Clinical trial to compare efficacy and side-effects of injection of posterior sub-tenon triamcinolone versus orbital floor methylprednisolone in the management of posterior uveitis Clin Exp Ophthalmol 32 563 568 10.1111/j.1442-9071.2004.00902.x (Pubitemid 40074099)
10. Wang JJ, Rochtchina E, Tan AG, Cumming RG, Leeder SR, Mitchell P (2009) Use of inhaled and oral corticosteroids and the long-term risk of cataract. Ophthalmology 116(4):652-657
11. P Neri A Azuara-Blanco JV Forrester 2004 Incidence of glaucoma in patients with uveitis J Glaucoma 13 6 461 465 10.1097/01.ijg.0000146391.77618.d0 15534470 (Pubitemid 39546339)
12. C Dees JJ Arnold JV Forrester AD Dick 1998 Immunosuppressive treatment of choroidal neovascularization associated with endogenous posterior uveitis Arch Ophthalmol 116 11 1456 1461 1:CAS:528:DyaK1cXnsFGmsr8%3D 9823346
13. AH Enk J Knop 1997 Treatment of pemphigus vulgaris with mycophenolate mofetil Lancet 350 494 1:STN:280:DyaK2svitVSrug%3D%3D 10.1016/S0140-6736(05) 63084-X 9274594 (Pubitemid 27343313)
14. R Goldblum 1993 Therapy of rheumatoid arthritis with mycophenolate mofetil Clin Exp Rheumatol 11 Suppl 8 S1117 S1119
15. S Spatz A Rudnicka CJ McDonald 1978 Mycophenolic acid in psoriasis Br J Dermatol 98 429 435 1:STN:280:DyaE1c7ksVKhsw%3D%3D 10.1111/j.1365-2133.1978. tb06537.x 346042
16. DJ Kilmartin JV Forrester AD Dick 1998 Rescue therapy with mycophenolate mofetil in refractory uveitis Lancet 352 35 36 1:STN:280:DyaK1M%2FhsFenug%3D%3D 10.1016/S0140-6736(05)79515-5 9800750 (Pubitemid 28306570)
17. JE Thorne DA Jabs FA Qazi QD Nguyen JH Kempen JP Dunn 2005 Mycophenolate mofetil therapy for inflammatory eye disease Ophthalmology 112 8 1472 1477 10.1016/j.ophtha.2005.02.020 16061096 (Pubitemid 41074642)
18. K Siepmann M Huber N Stübiger C Deuter M Zierhut 2006 Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis. A retrospective analysis of 106 patients Graefes Arch Clin Exp Ophthalmol 244 788 794 1:CAS:528:DC%2BD28XntVSms7g%3D 10.1007/s00417-005-0066-8 16163494 (Pubitemid 44103323)
19. D Espinosa-Heidmann IJ Suner EP Hernandez, et al. 2003 Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization Invest Ophthalmol Vis Sci 44 3586 3592 10.1167/iovs.03-0038 12882811 (Pubitemid 36909799)
20. VM Reddy RL Zamora HJ Kaplan 1995 Distribution of growth factors in subfoveal neovascular membranes in age-related macular degeneration and presumed ocular histoplasmosis syndrome Am J Ophthalmol 120 291 301 1:CAS:528: DyaK2MXos1ChsrY%3D 7661200
21. J Levy M Shneck I Klemperer, et al. 2005 Punctate inner choroidopathy: resolution after oral steroid treatment and review of the literature Can J Ophthalmol 40 5 605 608 16391624
22. AD Dick 2005 Are we still reluctant to immunosuppress? Clin Exp Ophthalmol 33 1 1 2 10.1111/j.1442-9071.2004.00935.x (Pubitemid 40330966)
23. HW Sollinger 1995 US renal transplant mycophenolate mofetil study group. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients Transplantation 60 225 232 1:CAS:528: DyaK2MXosVCiu78%3D 10.1097/00007890-199508000-00003 7645033
24. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group 1996 A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation Transplantation 61 1029 1037 10.1097/00007890-199604150-00008 (Pubitemid 26120252)
25. R Nowack U Gobel P Klooker O Hergesell K Andrassy FJ van der Wounde 1999 Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement J Am Soc Nephrol 10 9 1965 1971 1:CAS:528:DyaK1MXmtVSmt7o%3D 10477149
26. W Miehsler W Reinisch G Moser A Gangl H Vogelsang 2001 Is mycophenolate mofetil an effective alternative in azathioprine-intolerant patients with chronic active Crohn's disease? Am J Gastroenterol 96 3 782 787 1:CAS:528:DC%2BD3MXivFCnt70%3D 10.1111/j.1572-0241.2001.03622.x 11280551
27. A Benez G Fierlbeck 2001 Successful long-term treatment of severe atopic dermatitis with mycophenolate mofetil Br J Dermatol 144 3 638 639 1:STN:280:DC%2BD3M7mtFGitA%3D%3D 10.1046/j.1365-2133.2001.04108.x 11260038 (Pubitemid 32232035)
28. U Disel S Pavdas A Dogan G Gulfiliz S Yavuz 2004 Effect of colchicine on cyclosporine nephrotoxicity, reduction of TGF-beta overexpression, apoptosis, and oxidative damage: an experimental animal study Transplant Proc 36 5 1372 1376 1:CAS:528:DC%2BD2cXlsFyktLY%3D 10.1016/j.transproceed.2004.05.078 15251335 (Pubitemid 38902980)
29. M Naesens DR Kuypers M Sarwal 2009 Calcineurin inhibitor nephrotoxicity Clin J Am Soc Nephrol 4 2 481 508 1:CAS:528:DC%2BD1MXjslagurc%3D 19218475
30. R Yamanaka N Ogata C Yamamoto M Matsushita K Matsuzaki M Uyama M Matsumura 2002 Expression of transforming growth factor-beta receptors in normal rat retina, experimental choroidal neovascularization Jpn J Ophthalmol 46 5 525 532 1:CAS:528:DC%2BD38XoslKktrs%3D 10.1016/S0021-5155(02)00536-1 12457911 (Pubitemid 35380006)
31. RM Clancy JP Buyon 2003 Clearance of apoptotic cells: TGF-beta in the balance between inflammation and fibrosis J Leukoc Biol 74 6 959 960 1:CAS:528:DC%2BD3sXpvFejsbk%3D 10.1189/jlb.0603276 12960252 (Pubitemid 38040315)
32. FS Shihab WM Bennett H Yi SO Choi TF Andoh 2003 Mycophenolate mofetil ameliorates arteriolopathy and decreases transforming growth factor-beta 1 in chronic cyclosporine nephrotoxicity Am J Transplant 3 12 1550 1559 1:CAS:528:DC%2BD2cXktlGmtg%3D%3D 10.1046/j.1600-6135.2003.00244.x 14629285 (Pubitemid 37541512)
33. CH Lau M Comer S Lightmen 2003 Long-term efficacy of mycophenolate mofetil in the control of severe intraocular inflammation Clin Exp Ophthalmol 31 6 487 491 10.1046/j.1442-9071.2003.00704.x (Pubitemid 38049225)
34. M Allison EM Eugui 2000 Mycophenolate mofetil and its mechanism of action Immunopharmacology 47 85 118 1:CAS:528:DC%2BD3cXktlKkt7o%3D 10.1016/S0162-3109(00)00188-0 10878285 (Pubitemid 30394534)
35. TH Tran C Fardeau C Terrada G Ducos De Lahitte B Bodaghi P Lehoang 2008 Intravitreal bevacizumab for refractory choroidal neovascularization (CNV) secondary to uveitis Graefes Arch Clin Exp Ophthalmol 246 12 1685 1692 1:CAS:528:DC%2BD1cXhtlart7bN 10.1007/s00417-008-0906-4 18682970